Renal Allograft Function and the Tacrolimus C/D Ratio: Insights from a Prospective Study on MeltDose Tacrolimus
Authors:
- Alicja Dębska-ŚlizieńAlicja Dębska-Ślizień
- Izabella Kuźmiuk-GlembinIKIzabella Kuźmiuk-Glembin
- Roman HożejowskiRHRoman Hożejowski
- Dorota KamińskaDorota Kamińska
- Magdalena KrajewskaMKMagdalena Krajewska
- Anna Zawiasa-BryszewskaAZAnna Zawiasa-Bryszewska
- Ilona KurnatowskaIKIlona Kurnatowska
- Katarzyna Smykał-JankowiakKSKatarzyna Smykał-Jankowiak
- Maciej GłydaMGMaciej Głyda
- Lidia KoziołLKLidia Kozioł
- Marek KarczewskiMKMarek Karczewski
- Kazimierz CiechanowskiKCKazimierz Ciechanowski
Open Access
- 19 October 2024
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (20) , 6241
Abstract
Background: The tacrolimus concentration-to-dose (C/D) ratio is valuable for optimizing nephrotoxicity-related renal outcomes. Prospective data on the C/D ratio in kidney transplant recipients newly treated with MeltDose tacrolimus are limited. We analyzed the C/D ratio pattern of MeltDose tacrolimus and its effect on posttransplant renal function, comparing it with the literature data on immediate-release tacrolimus (IR-Tac). Methods: In total, 101 adult kidney transplant recipients on a standard immunosuppressive regimen including MeltDose tacrolimus were enrolled in this prospective, multicenter cohort study and followed for 12 months. The C/D ratio classified patients as fast, intermediate, or slow metabolizers. Renal function was assessed via the estimated glomerular filtration rate (eGFR). MeltDose tacrolimus data were compared with previous IR-Tac data by bootstrapping. Results: The cohort exhibited a right-skewed C/D ratio distribution with a mean of 2.12 ng/mL × 1/mg, which was significantly greater than the 1.29 mean for IR-Tac (p < 0.001). Compared with fast metabolizers, slow metabolizers of MeltDose tacrolimus experienced greater eGFR gains at 6 months post-transplantation (median +7.9 vs. −3.6 mL/min; p = 0.005). A Bayesian linear mixed-effects model predicting the eGFR at month 12 identified the baseline eGFR, time from transplant, body mass index, and log-transformed C/D ratio as significant variables. A one-unit increase in the log-transformed C/D ratio corresponded to an approximate increase of 4.5 mL/min in the eGFR at month 12. Conclusions: Slow metabolizers of MeltDose tacrolimus had significantly better renal function outcomes than fast metabolizers. MeltDose tacrolimus is associated with slower metabolism than is IR-Tac, as evidenced by its higher C/D ratios.Keywords
Funding Information
- Chiesi Poland Sp. z o.o.
This publication has 30 references indexed in Scilit:
- Genotype‐Guided Model for Prediction of Tacrolimus Initial Dosing After Lung TransplantationThe Journal of Clinical Pharmacology, 2024
- Association of high intra-patient variability in tacrolimus exposure with calcineurin inhibitor nephrotoxicity in kidney transplantationScientific Reports, 2023
- Physiologically based pharmacokinetic model combined with reverse dose method to study the nephrotoxic tolerance dose of tacrolimusArchives of Toxicology, 2023
- Increased renal function decline in fast metabolizers using extended-release tacrolimus after kidney transplantationScientific Reports, 2021
- The TOMATO Study (Tacrolimus Metabolization in Kidney Transplantation): Impact of the Concentration–Dose Ratio on Death-censored Graft SurvivalTransplantation, 2020
- C/D Ratio in Long-Term Renal FunctionTransplantation Proceedings, 2019
- Long-Term Clinical Impact of Adaptation of Initial Tacrolimus Dosing to CYP3A5 GenotypeAmerican Journal of Transplantation, 2016
- BK Polyomavirus Replication in Renal Tubular Epithelial Cells Is Inhibited by Sirolimus, but Activated by Tacrolimus Through a Pathway Involving FKBP-12American Journal of Transplantation, 2015
- Pharmacokinetic interaction between corticosteroids and tacrolimus after renal transplantationNephrology Dialysis Transplantation, 2003
- Bootstrap confidence intervals: when, which, what? A practical guide for medical statisticiansStatistics in Medicine, 2000